April 28, 2025

Delgocitinib Cream Outperforms Alitretinoin in Trial

Topical delgocitinib improved eczema severity scores and caused fewer adverse events than oral alitretinoin in adults with severe chronic hand eczema, according to a phase 3 study.

Conexiant

April 28, 2025

Granuloma Annulare: Which Light Heals Best?

Given their favorable adverse event profiles and demonstrated efficacy, both UVA-1 therapy and bath-PUVA therapy should be preferred treatment options for patients with granuloma annulare, according to a 10-year study comparing phototherapy modalities.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 17, 2025

We Want Your Perspective!

Join our roster of respected specialists and share your clinical perspectives.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

April 08, 2025

Biomarkers Identified in Steroid Withdrawal

Distinct clinical and molecular features of topical steroid withdrawal, identifying potential therapeutic targets and diagnostic criteria.

Conexiant

April 08, 2025

Link Between Gut Microbiota and Skin Inflammation Uncovered

IL-15RA mediated 11% of the pathway between Veillonellaceae and eczema, supporting a role for inflammatory proteins in the gut-skin axis.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

August 12, 2024

Study: U.S. Child Allergy Rates Shifted During Pandemic

A recent study investigated the prevalence of allergies and asthma among U.S. children during and before the COVID-19 pandemic, revealing changes in allergy prevalence and potential associations with pandemic-related lifestyle changes.

Conexiant